1. Home
  2. GRPN vs EVO Comparison

GRPN vs EVO Comparison

Compare GRPN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRPN
  • EVO
  • Stock Information
  • Founded
  • GRPN 2008
  • EVO 1993
  • Country
  • GRPN United States
  • EVO Germany
  • Employees
  • GRPN N/A
  • EVO 4766
  • Industry
  • GRPN Advertising
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRPN Consumer Discretionary
  • EVO Health Care
  • Exchange
  • GRPN Nasdaq
  • EVO Nasdaq
  • Market Cap
  • GRPN 1.2B
  • EVO 1.4B
  • IPO Year
  • GRPN 2011
  • EVO 2021
  • Fundamental
  • Price
  • GRPN $20.24
  • EVO $3.89
  • Analyst Decision
  • GRPN Buy
  • EVO Strong Buy
  • Analyst Count
  • GRPN 4
  • EVO 1
  • Target Price
  • GRPN $31.25
  • EVO $7.00
  • AVG Volume (30 Days)
  • GRPN 1.3M
  • EVO 50.7K
  • Earning Date
  • GRPN 11-11-2025
  • EVO 11-05-2025
  • Dividend Yield
  • GRPN N/A
  • EVO N/A
  • EPS Growth
  • GRPN N/A
  • EVO N/A
  • EPS
  • GRPN N/A
  • EVO N/A
  • Revenue
  • GRPN $487,747,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • GRPN $4.78
  • EVO N/A
  • Revenue Next Year
  • GRPN $10.96
  • EVO $10.78
  • P/E Ratio
  • GRPN N/A
  • EVO N/A
  • Revenue Growth
  • GRPN N/A
  • EVO N/A
  • 52 Week Low
  • GRPN $7.75
  • EVO $2.84
  • 52 Week High
  • GRPN $43.08
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • GRPN 32.51
  • EVO 54.96
  • Support Level
  • GRPN $20.11
  • EVO $3.81
  • Resistance Level
  • GRPN $22.30
  • EVO $4.06
  • Average True Range (ATR)
  • GRPN 1.10
  • EVO 0.08
  • MACD
  • GRPN -0.02
  • EVO 0.01
  • Stochastic Oscillator
  • GRPN 3.43
  • EVO 64.13

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: